Amrutanjan Healt

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE098F01031
NSEID: AMRUTANJAN
BSEID: 590006

INR

659.90

-6.15 (-0.92%)

BSENSE

Dec 05

BSE+NSE Vol: 9.28 k

{
  "main_header": {
    "sid": 149140,
    "name": "Amrutanjan Healt",
    "stock_name": "Amrutanjan Healt",
    "full_name": "Amrutanjan Health Care Ltd",
    "name_url": "stocks-analysis/amrutanjan-healt",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "659.90",
    "chg": -6.15,
    "chgp": "-0.92%",
    "dir": -1,
    "prev_price": "666.05",
    "mcapval": "1,931.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 590006,
    "symbol": "AMRUTANJAN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE098F01031",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "9.28 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/amrutanjan-healt-149140-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Amrutanjan Healt falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-amrutanjan-healt-fallingrising-3742412",
        "imagepath": "",
        "date": "2025-12-03 00:40:33",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Performance and Market Comparison</strong></p>\n<p>Amrutanjan Health Care’s recent price trajectory has been disappointing when compared to the broader market. Over the past week, the stock declined by 1.68%, whereas the Sensex gained 0.65%. This divergence has widened over longer periods, with the stock falling 7.40% in the last month while the Sensex rose 1.43%. Year-to-date figures further highlight this underperformance, with Amrutanjan down 7.58% against the Sensex’s 8.96% gain. Even over a one-year horizon, the stock has declined by 9.32%, contrasting with the Sensex’s positive 6.09% return. These figures underscore a persistent lag in the company’s share price relative to the broader market.</p>\n<p><strong>Technical Indicators and Investor Participation</strong></p>\n<p>Tec..."
      },
      {
        "title": "Amrutanjan Health Care Faces Mildly Bearish Technical Momentum Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/amrutanjan-health-care-faces-mildly-bearish-momentum-amid-technical-shifts-3727305",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AmrutanjanHealt_technicaldot_3727305.png",
        "date": "2025-11-25 08:00:53",
        "description": "Amrutanjan Health Care's recent technical indicators reveal a shift towards a mildly bearish momentum, reflecting evolving market dynamics within the Pharmaceuticals & Biotechnology sector. The stock's price movements and key technical signals suggest cautious investor sentiment amid broader market fluctuations."
      },
      {
        "title": "Is Amrutanjan Healt technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-amrutanjan-healt-technically-bullish-or-bearish-3713812",
        "imagepath": "",
        "date": "2025-11-19 08:13:48",
        "description": "As of 18 November 2025, the technical trend has changed from mildly bullish to sideways. The current technical stance is neutral, with mixed signals across different time frames. The weekly MACD is mildly bearish, while the monthly MACD remains bullish, indicating conflicting momentum. The Bollinger Bands are bearish on both weekly and monthly charts, suggesting downward pressure. Daily moving averages show a mildly bullish stance, but overall, the lack of clear signals from the RSI and Dow Theory, which indicate no trend in both weekly and monthly views, reinforces the neutral outlook. The stock's recent performance is underwhelming compared to the Sensex, with negative returns over multiple periods, further contributing to the sideways trend...."
      },
      {
        "title": "Amrutanjan Health Care Sees Adjustment in Evaluation Amid Mixed Technical and Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/amrutanjan-health-care-downgraded-to-hold-by-marketsmojo-on-technical-concerns-3714365",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AmrutanjanHealt_mojoScore_3714365.png",
        "date": "2025-11-19 08:10:07",
        "description": "Amrutanjan Health Care, a key player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its evaluation reflecting nuanced shifts across technical trends, valuation metrics, financial performance, and quality indicators. The stock’s recent performance and underlying fundamentals present a complex picture for investors navigating the current market environment."
      },
      {
        "title": "Amrutanjan Health Care Technical Momentum Shifts Amid Sideways Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/amrutanjan-health-care-technical-momentum-shifts-amid-sideways-trend-3714112",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AmrutanjanHealt_technicaldot_3714112.png",
        "date": "2025-11-19 08:00:42",
        "description": "Amrutanjan Health Care has experienced a shift in its technical momentum, moving from a mildly bullish stance to a sideways trend as of November 2025. The stock’s current price stands at ₹708.15, slightly below its previous close of ₹710.40, reflecting a day change of -0.32%. This movement occurs within the Pharmaceuticals & Biotechnology sector, where technical indicators present a mixed picture for investors analysing price momentum and trend direction."
      },
      {
        "title": "How has been the historical performance of Amrutanjan Healt?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-amrutanjan-healt-3713143",
        "imagepath": "",
        "date": "2025-11-18 22:57:25",
        "description": "Answer:\nThe historical performance of Amrutanjan Healt shows a consistent growth trend in net sales and profits over the years, particularly from 2011 to 2017.\n\nBreakdown:\nAmrutanjan Healt's net sales increased from 105.41 Cr in March 2011 to 231.70 Cr in March 2017, reflecting a strong upward trajectory. Other operating income also rose, contributing to total operating income growth from 105.41 Cr in 2011 to 234.59 Cr in 2017. The company's total expenditure, excluding depreciation, rose from 92.46 Cr in 2011 to 205.57 Cr in 2017, indicating increased operational costs alongside revenue growth. Operating profit (PBDIT) saw fluctuations, peaking at 36.34 Cr in March 2016 before slightly declining to 33.85 Cr in March 2017. Profit before tax increased from 15.60 Cr in 2011 to 33.24 Cr in 2017, while profit after tax reached 21.14 Cr in 2017, up from 10.43 Cr in 2011. The earnings per share (EPS) also improve..."
      },
      {
        "title": "Has Amrutanjan Healt declared dividend?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/has-amrutanjan-healt-declared-dividend-3694239",
        "imagepath": "",
        "date": "2025-11-12 23:31:25",
        "description": "Amrutanjan Health Care Ltd has declared a 100% dividend.\n\nDividend Details:\n- Percentage announced: 100%\n- Amount per share: 2.6\n- Ex-date: 18 Nov 25\n\nDividend Yield: 0.64%.\n\nTotal Returns by Period:\nIn the last 3 months, the price return was 5.8%, the dividend return was 0.52%, resulting in a total return of 6.32%.\n\nOver the past 6 months, the price return was 0.84%, the dividend return was 0.51%, leading to a total return of 1.35%.\n\nFor the 1-year period, the price return was 6.47%, the dividend return was 0.80%, culminating in a total return of 7.27%.\n\nIn the 2-year span, the price return was 17.72%, the dividend return was 1.54%, which resulted in a total return of 19.26%.\n\nDuring the 3-year period, the price return was -2.78%, the dividend return was 1.96%, resulting in a total return of -0.82%.\n\nOver the last 4 years, the price return was -25.31%, the dividend return was 2.03%, leading to a total retu..."
      },
      {
        "title": "How has been the historical performance of Amrutanjan Healt?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-amrutanjan-healt-3693821",
        "imagepath": "",
        "date": "2025-11-12 23:14:37",
        "description": "Answer:\nThe historical performance of Amrutanjan Healt shows a steady growth in net sales and profitability over the years, with net sales increasing from 140.41 Cr in March 2014 to 231.70 Cr in March 2017. The total operating income also rose significantly, reaching 234.59 Cr in March 2017, up from 141.73 Cr in March 2014. Operating profit, excluding other income, peaked at 29.02 Cr in March 2017, although it showed a slight decline from the previous year. Profit before tax increased to 33.24 Cr in March 2017, while profit after tax reached 21.14 Cr, reflecting a consistent upward trend in profitability. The earnings per share (EPS) also improved, reaching 7.23 in March 2017 compared to 4.26 in March 2014. \n\nBreakdown:\nAmrutanjan Healt's financial performance from 2011 to 2017 indicates a robust growth trajectory, particularly in net sales, which climbed from 140.41 Cr in March 2014 to 231.70 Cr in March 2..."
      },
      {
        "title": "Are Amrutanjan Healt latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-amrutanjan-healt-latest-results-good-or-bad-3690450",
        "imagepath": "",
        "date": "2025-11-11 19:31:56",
        "description": "Amrutanjan Health Care's latest financial results for Q2 FY26 reflect a notable seasonal recovery, with net sales reaching ₹117.70 crores, marking a year-on-year growth of 7.08%. This growth is a deceleration compared to the previous year's performance, which saw a higher growth rate. The company's net profit for the quarter stood at ₹13.96 crores, indicating an 18.31% increase year-on-year, although this is also a reduction from prior growth rates.\n\nThe operating margin improved significantly to 14.04%, up from 12.37% in the same quarter last year, showcasing enhanced operational efficiency. This margin expansion is attributed to better cost management and the seasonal nature of demand for the company's products, particularly during the monsoon and early winter months when cold-related ailments drive consumption.\n\nDespite the positive operational metrics, the company experienced a decline in its market cap..."
      }
    ],
    "total": 486,
    "sid": "149140",
    "stock_news_url": "https://www.marketsmojo.com/news/amrutanjan-health-care-149140"
  },
  "announcements": [
    {
      "caption": "Investor Presentation For The Quarter Ended 30Th September 2025",
      "datetime": "11-Nov-2025",
      "details": "Investor Presentation for the Quarter Ended 30th September 2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025",
      "datetime": "10-Nov-2025",
      "details": "Unaudited Financial results for the quarter and half year ended September 30 2025",
      "source": "BSE"
    },
    {
      "caption": "Record Date For The First Interim Dividend Is 18 November 2025.",
      "datetime": "10-Nov-2025",
      "details": "Record date for the first interim dividend is 18 November 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Amrutanjan Health Care Ltd has declared <strong>100%</strong> dividend, ex-date: 18 Nov 25",
          "dt": "2025-11-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Amrutanjan Health Care Ltd has announced <strong>1:2</strong> stock split, ex-date: 13 Apr 18",
          "dt": "2018-04-13",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Amrutanjan Healt falling/rising?

2025-12-03 00:40:33

Recent Price Performance and Market Comparison

Amrutanjan Health Care’s recent price trajectory has been disappointing when compared to the broader market. Over the past week, the stock declined by 1.68%, whereas the Sensex gained 0.65%. This divergence has widened over longer periods, with the stock falling 7.40% in the last month while the Sensex rose 1.43%. Year-to-date figures further highlight this underperformance, with Amrutanjan down 7.58% against the Sensex’s 8.96% gain. Even over a one-year horizon, the stock has declined by 9.32%, contrasting with the Sensex’s positive 6.09% return. These figures underscore a persistent lag in the company’s share price relative to the broader market.

Technical Indicators and Investor Participation

Tec...

Amrutanjan Health Care Faces Mildly Bearish Technical Momentum Amid Market Challenges

2025-11-25 08:00:53

Amrutanjan Health Care's recent technical indicators reveal a shift towards a mildly bearish momentum, reflecting evolving market dynamics within the Pharmaceuticals & Biotechnology sector. The stock's price movements and key technical signals suggest cautious investor sentiment amid broader market fluctuations.

Is Amrutanjan Healt technically bullish or bearish?

2025-11-19 08:13:48

As of 18 November 2025, the technical trend has changed from mildly bullish to sideways. The current technical stance is neutral, with mixed signals across different time frames. The weekly MACD is mildly bearish, while the monthly MACD remains bullish, indicating conflicting momentum. The Bollinger Bands are bearish on both weekly and monthly charts, suggesting downward pressure. Daily moving averages show a mildly bullish stance, but overall, the lack of clear signals from the RSI and Dow Theory, which indicate no trend in both weekly and monthly views, reinforces the neutral outlook. The stock's recent performance is underwhelming compared to the Sensex, with negative returns over multiple periods, further contributing to the sideways trend....

Amrutanjan Health Care Sees Adjustment in Evaluation Amid Mixed Technical and Financial Signals

2025-11-19 08:10:07

Amrutanjan Health Care, a key player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its evaluation reflecting nuanced shifts across technical trends, valuation metrics, financial performance, and quality indicators. The stock’s recent performance and underlying fundamentals present a complex picture for investors navigating the current market environment.

Amrutanjan Health Care Technical Momentum Shifts Amid Sideways Trend

2025-11-19 08:00:42

Amrutanjan Health Care has experienced a shift in its technical momentum, moving from a mildly bullish stance to a sideways trend as of November 2025. The stock’s current price stands at ₹708.15, slightly below its previous close of ₹710.40, reflecting a day change of -0.32%. This movement occurs within the Pharmaceuticals & Biotechnology sector, where technical indicators present a mixed picture for investors analysing price momentum and trend direction.

How has been the historical performance of Amrutanjan Healt?

2025-11-18 22:57:25

Answer: The historical performance of Amrutanjan Healt shows a consistent growth trend in net sales and profits over the years, particularly from 2011 to 2017. Breakdown: Amrutanjan Healt's net sales increased from 105.41 Cr in March 2011 to 231.70 Cr in March 2017, reflecting a strong upward trajectory. Other operating income also rose, contributing to total operating income growth from 105.41 Cr in 2011 to 234.59 Cr in 2017. The company's total expenditure, excluding depreciation, rose from 92.46 Cr in 2011 to 205.57 Cr in 2017, indicating increased operational costs alongside revenue growth. Operating profit (PBDIT) saw fluctuations, peaking at 36.34 Cr in March 2016 before slightly declining to 33.85 Cr in March 2017. Profit before tax increased from 15.60 Cr in 2011 to 33.24 Cr in 2017, while profit after tax reached 21.14 Cr in 2017, up from 10.43 Cr in 2011. The earnings per share (EPS) also improve...

Has Amrutanjan Healt declared dividend?

2025-11-12 23:31:25

Amrutanjan Health Care Ltd has declared a 100% dividend. Dividend Details: - Percentage announced: 100% - Amount per share: 2.6 - Ex-date: 18 Nov 25 Dividend Yield: 0.64%. Total Returns by Period: In the last 3 months, the price return was 5.8%, the dividend return was 0.52%, resulting in a total return of 6.32%. Over the past 6 months, the price return was 0.84%, the dividend return was 0.51%, leading to a total return of 1.35%. For the 1-year period, the price return was 6.47%, the dividend return was 0.80%, culminating in a total return of 7.27%. In the 2-year span, the price return was 17.72%, the dividend return was 1.54%, which resulted in a total return of 19.26%. During the 3-year period, the price return was -2.78%, the dividend return was 1.96%, resulting in a total return of -0.82%. Over the last 4 years, the price return was -25.31%, the dividend return was 2.03%, leading to a total retu...

How has been the historical performance of Amrutanjan Healt?

2025-11-12 23:14:37

Answer: The historical performance of Amrutanjan Healt shows a steady growth in net sales and profitability over the years, with net sales increasing from 140.41 Cr in March 2014 to 231.70 Cr in March 2017. The total operating income also rose significantly, reaching 234.59 Cr in March 2017, up from 141.73 Cr in March 2014. Operating profit, excluding other income, peaked at 29.02 Cr in March 2017, although it showed a slight decline from the previous year. Profit before tax increased to 33.24 Cr in March 2017, while profit after tax reached 21.14 Cr, reflecting a consistent upward trend in profitability. The earnings per share (EPS) also improved, reaching 7.23 in March 2017 compared to 4.26 in March 2014. Breakdown: Amrutanjan Healt's financial performance from 2011 to 2017 indicates a robust growth trajectory, particularly in net sales, which climbed from 140.41 Cr in March 2014 to 231.70 Cr in March 2...

Are Amrutanjan Healt latest results good or bad?

2025-11-11 19:31:56

Amrutanjan Health Care's latest financial results for Q2 FY26 reflect a notable seasonal recovery, with net sales reaching ₹117.70 crores, marking a year-on-year growth of 7.08%. This growth is a deceleration compared to the previous year's performance, which saw a higher growth rate. The company's net profit for the quarter stood at ₹13.96 crores, indicating an 18.31% increase year-on-year, although this is also a reduction from prior growth rates. The operating margin improved significantly to 14.04%, up from 12.37% in the same quarter last year, showcasing enhanced operational efficiency. This margin expansion is attributed to better cost management and the seasonal nature of demand for the company's products, particularly during the monsoon and early winter months when cold-related ailments drive consumption. Despite the positive operational metrics, the company experienced a decline in its market cap...

View All News